| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5834448 | BTG INTL | Dosage form of hydroxocobalamin and its use in cyanide poisoning |
Nov, 2016
(7 years ago) | |
Cyanokit is owned by Btg Intl.
Cyanokit contains Hydroxocobalamin.
Cyanokit has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Cyanokit are:
- US5834448
Cyanokit was authorised for market use on 15 December, 2006.
Cyanokit is available in injectable;injection dosage forms.
The generics of Cyanokit are possible to be released after 14 November, 2016.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| Orphan Drug Exclusivity(ODE) | Dec 15, 2013 |
Drugs and Companies using HYDROXOCOBALAMIN ingredient
Market Authorisation Date: 15 December, 2006
Treatment: NA
Dosage: INJECTABLE;INJECTION
More Information on Dosage
CYANOKIT family patents
